Clinical Trial Update: Vactosertib and Durvalumab in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for Vactosertib with Durvalumab in stomach neoplasm (gastric cancer) is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Neoplasm

Drugs mentioned

• Durvalumab (durvalumab)
• Vactosertib (Vactosertib)

Snippet

Sponsor: Hark Kyun Kim | Conditions: Stomach Neoplasm | Phase 2 | Status: UNKNOWN